HIGHLIGHTS
- who: Virginie Marcel and colleagues from the Department, Lyon, France, Anticancer antibodies team, Immunity, Microenvironment and Virus Editor: have published the paper: Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0170160]. January 19, 2017 of /1371/
- what: The authors focused the study on genes encoding factors regulating either ribosome production, such as nucleolin (NCL) and fibrillarin (FBL), or ribosome composition -such as FBL, NOP56, NOP58 and NHP2L1.
- how: The data are compatible . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.